390 related articles for article (PubMed ID: 11834532)
1. Cellular antioxidant effects of atorvastatin in vitro and in vivo.
Wassmann S; Laufs U; Müller K; Konkol C; Ahlbory K; Bäumer AT; Linz W; Böhm M; Nickenig G
Arterioscler Thromb Vasc Biol; 2002 Feb; 22(2):300-5. PubMed ID: 11834532
[TBL] [Abstract][Full Text] [Related]
2. HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species.
Wassmann S; Laufs U; Bäumer AT; Müller K; Ahlbory K; Linz W; Itter G; Rösen R; Böhm M; Nickenig G
Hypertension; 2001 Jun; 37(6):1450-7. PubMed ID: 11408394
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: involvement of angiotensin AT1 receptor expression and Rac1 GTPase.
Wassmann S; Laufs U; Bäumer AT; Müller K; Konkol C; Sauer H; Böhm M; Nickenig G
Mol Pharmacol; 2001 Mar; 59(3):646-54. PubMed ID: 11179461
[TBL] [Abstract][Full Text] [Related]
4. Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II.
Touyz RM; Chen X; Tabet F; Yao G; He G; Quinn MT; Pagano PJ; Schiffrin EL
Circ Res; 2002 Jun; 90(11):1205-13. PubMed ID: 12065324
[TBL] [Abstract][Full Text] [Related]
5. NADPH oxidase isoforms and anti-hypertensive effects of atorvastatin demonstrated in two animal models.
Cui W; Matsuno K; Iwata K; Ibi M; Katsuyama M; Kakehi T; Sasaki M; Ikami K; Zhu K; Yabe-Nishimura C
J Pharmacol Sci; 2009 Nov; 111(3):260-8. PubMed ID: 19881226
[TBL] [Abstract][Full Text] [Related]
6. Withdrawal of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors elicits oxidative stress and induces endothelial dysfunction in mice.
Vecchione C; Brandes RP
Circ Res; 2002 Jul; 91(2):173-9. PubMed ID: 12142351
[TBL] [Abstract][Full Text] [Related]
7. Atorvastatin ameliorates arsenic-induced hypertension and enhancement of vascular redox signaling in rats.
Sarath TS; Waghe P; Gupta P; Choudhury S; Kannan K; Pillai AH; Harikumar SK; Mishra SK; Sarkar SN
Toxicol Appl Pharmacol; 2014 Nov; 280(3):443-54. PubMed ID: 25218292
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of Nad(P)H oxidase isoforms and the effects of atorvastatin on cardiac remodeling in two-kidney two-clip hypertensive rats.
Li R; Fang W; Cao S; Li Y; Wang J; Xi S; Zhang B; He Y
Pharmazie; 2013 Apr; 68(4):261-9. PubMed ID: 23700792
[TBL] [Abstract][Full Text] [Related]
9. Reactive oxygen species derived from NADPH oxidase 1 and mitochondria mediate angiotensin II-induced smooth muscle cell senescence.
Tsai IC; Pan ZC; Cheng HP; Liu CH; Lin BT; Jiang MJ
J Mol Cell Cardiol; 2016 Sep; 98():18-27. PubMed ID: 27381955
[TBL] [Abstract][Full Text] [Related]
10. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors upregulate inducible NO synthase expression and activity in vascular smooth muscle cells.
Kolyada AY; Fedtsov A; Madias NE
Hypertension; 2001 Nov; 38(5):1024-9. PubMed ID: 11711492
[TBL] [Abstract][Full Text] [Related]
11. Atorvastatin prevents angiotensin II-induced vascular remodeling and oxidative stress.
Briones AM; Rodríguez-Criado N; Hernanz R; García-Redondo AB; Rodrigues-Díez RR; Alonso MJ; Egido J; Ruiz-Ortega M; Salaices M
Hypertension; 2009 Jul; 54(1):142-9. PubMed ID: 19451411
[TBL] [Abstract][Full Text] [Related]
12. Glucose increases endothelial-dependent superoxide formation in coronary arteries by NAD(P)H oxidase activation: attenuation by the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor atorvastatin.
Christ M; Bauersachs J; Liebetrau C; Heck M; Günther A; Wehling M
Diabetes; 2002 Aug; 51(8):2648-52. PubMed ID: 12145183
[TBL] [Abstract][Full Text] [Related]
13. Vascular injury in diabetic db/db mice is ameliorated by atorvastatin: role of Rac1/2-sensitive Nox-dependent pathways.
Bruder-Nascimento T; Callera GE; Montezano AC; He Y; Antunes TT; Nguyen Dinh Cat A; Tostes RC; Touyz RM
Clin Sci (Lond); 2015 Apr; 128(7):411-23. PubMed ID: 25358739
[TBL] [Abstract][Full Text] [Related]
14. Raloxifene improves endothelial dysfunction in hypertension by reduced oxidative stress and enhanced nitric oxide production.
Wassmann S; Laufs U; Stamenkovic D; Linz W; Stasch JP; Ahlbory K; Rösen R; Böhm M; Nickenig G
Circulation; 2002 Apr; 105(17):2083-91. PubMed ID: 11980689
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of gp91phox homologues of NAD(P)H oxidase in the aortic media during chronic hypertension: involvement of the renin-angiotensin system.
Akasaki T; Ohya Y; Kuroda J; Eto K; Abe I; Sumimoto H; Iida M
Hypertens Res; 2006 Oct; 29(10):813-20. PubMed ID: 17283869
[TBL] [Abstract][Full Text] [Related]
16. Atorvastatin inhibits homocysteine-induced oxidative stress and apoptosis in endothelial progenitor cells involving Nox4 and p38MAPK.
Bao XM; Wu CF; Lu GP
Atherosclerosis; 2010 May; 210(1):114-21. PubMed ID: 20018284
[TBL] [Abstract][Full Text] [Related]
17. Atorvastatin inhibits homocysteine-induced dysfunction and apoptosis in endothelial progenitor cells.
Bao XM; Wu CF; Lu GP
Acta Pharmacol Sin; 2010 Apr; 31(4):476-84. PubMed ID: 20305681
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms underlying recoupling of eNOS by HMG-CoA reductase inhibition in a rat model of streptozotocin-induced diabetes mellitus.
Wenzel P; Daiber A; Oelze M; Brandt M; Closs E; Xu J; Thum T; Bauersachs J; Ertl G; Zou MH; Förstermann U; Münzel T
Atherosclerosis; 2008 May; 198(1):65-76. PubMed ID: 18061195
[TBL] [Abstract][Full Text] [Related]
19. Atorvastatin reduces vascular endothelial growth factor (VEGF) expression in human non-small cell lung carcinomas (NSCLCs) via inhibition of reactive oxygen species (ROS) production.
Chen J; Liu B; Yuan J; Yang J; Zhang J; An Y; Tie L; Pan Y; Li X
Mol Oncol; 2012 Feb; 6(1):62-72. PubMed ID: 22153388
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of the vascular NAD(P)H-oxidase isoforms Nox1 and Nox4 by the renin-angiotensin system in vitro and in vivo.
Wingler K; Wünsch S; Kreutz R; Rothermund L; Paul M; Schmidt HH
Free Radic Biol Med; 2001 Dec; 31(11):1456-64. PubMed ID: 11728818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
